Moderna and Merck will start a phase 3 trial of the combination in adjuvant melanoma therapy later this year, and the proof-of-concept for this personalised neoantigen vaccine approach means that ...

Materials science articles from across Nature Portfolio Materials science is an interdisciplinary field concerned with the understanding and application of the properties of matter. Materials ...